Skip to main content
Livermore
Livermore
ZHEN

Petros Pharmaceuticals, Inc.

PTPI
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001815903

No open-market purchases or sales by Petros Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Holders of 5% or more of PTPI

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Petros Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of PTPI
HolderLatest formStakeChangeFirst filedLatest filingFiling
Iroquois Capital Management, LLC13G/A9.99%5.94M shares0.00 ppfrom 9.99%Feb 26, 20252 filingsMay 15, 2025SEC
Iroquois Capital Management, LLC13G/A9.99%3.31M shares–Aug 15, 20251 filingAug 15, 2025SEC
Ayrton Capital LLC13G/A6.20%657.6K shares–Feb 13, 20251 filingFeb 13, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Petros Pharmaceuticals, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on PTPI
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 15, 20258:00 AM ETIroquois Capital Management, LLCand 2 others13G/A9.99%3.31M shares–Jun 30, 2025SEC
May 15, 202510:15 AM ETIroquois Capital Management, LLCand 2 others13G/A9.99%5.94M shares0.00 ppfrom 9.99%Mar 31, 2025SEC
Feb 26, 20259:16 AM ETIroquois Capital Management, LLCand 2 others13G9.99%2.53M sharesNewFeb 17, 2025SEC
Feb 13, 20251:44 PM ETAyrton Capital LLCand 2 others13G/A6.20%657.6K shares–Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Petros Pharmaceuticals, Inc. shares.

No Form 144 notices for Petros Pharmaceuticals, Inc. are on file.